Three-dimensional neuronal models
Human-derived neuronal systems provide a more relevant context to study complex neural mechanisms.
Brain-on-Chip platform
Brain-on-Chip innovation into preclinical neuroscience research.
Human-relevant neuroscience
AxCellerate technology was developed to address a critical limitation in preclinical neuroscience: the gap between conventional experimental models and the complexity of human neuronal biology.
Traditional 2D cell cultures and animal models can provide useful information, but they often struggle to reproduce the structure, activity and functional behaviour of human neural systems. This can reduce the predictive value of early-stage research and increase uncertainty in drug development, disease modelling and safety assessment.
AxCellerate’s Brain-on-Chip platform is designed to create a more human-relevant experimental environment. It enables the culture, imaging and electrophysiological recording of three-dimensional neuronal models, supporting the investigation of neuronal activity, compound response, disease mechanisms and target biology.
How it works
The AxCellerate platform integrates biological, technological and analytical capabilities into an advanced in vitro system.
Human-derived neuronal systems provide a more relevant context to study complex neural mechanisms.
Microfabricated structures support controlled culture conditions and advanced experimental workflows.
Electrophysiological recording capabilities allow researchers to observe neuronal activity and network response.
The platform benefits from precision glass microfabrication, supporting transparency, biocompatibility and reduced compound absorption.
The system is designed to work with small amounts of cells and compounds and to support parallel experimental workflows.
Benefits
More meaningful preclinical evidence by combining human relevance, functional analysis and experimental flexibility.
More human-relevant preclinical models help teams investigate neural mechanisms in a context closer to human biology.
Functional insights into neuronal activity support early investigation of compound response, target biology and network behaviour.
The platform adds an advanced layer of evidence that can complement traditional workflows and strengthen translational research strategies.
Scientific foundation
AxCellerate technology originated from the EUROSTARS NEUROCHIP project, a European research initiative focused on developing a novel Brain-on-Chip model for neurological drug development.
The project combined expertise in precision glass microfabrication, microelectrode systems, neuroscience and innovative in vitro assays.
This scientific foundation led to the development of a platform designed to bring advanced Brain-on-Chip capabilities closer to real preclinical research needs.
Today, AxCellerate translates this technological foundation into B2B services for organizations working in neuroscience drug development, disease modelling, neurotoxicity assessment, compound screening, target validation and translational research.
Applications
AxCellerate’s Brain-on-Chip platform can support multiple research and industry needs across neuroscience and advanced safety assessment.
Support early-stage decisions for CNS-related therapeutic programs and strengthen the connection between preclinical findings and human biological relevance.
Supporting early-stage decisions for CNS-related therapeutic programs.
Strengthening the connection between preclinical findings and human biological relevance.
Study disease-related mechanisms in advanced human-relevant neuronal systems, including mutation-specific or tailored biological research questions.
Studying disease-related mechanisms in advanced human-relevant neuronal systems.
Exploring mutation-specific, disease-specific or tailored biological research questions.
Investigate adverse effects on neuronal activity, compare candidate compounds and generate early functional evidence.
Investigating potential adverse effects on neuronal activity and network response.
Comparing candidate compounds and generating early functional evidence.